Pier 88 Investment Partners’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-16,440
| Closed | -$716K | – | 102 |
|
|
2023
Q3 | $716K | Buy |
16,440
+8,550
| +108% | +$372K | 0.18% | 70 |
|
|
2023
Q2 | $285K | Buy |
7,890
+450
| +6% | +$16.3K | 0.07% | 83 |
|
|
2023
Q1 | $277K | Buy |
7,440
+3,350
| +82% | +$125K | 0.07% | 76 |
|
|
2022
Q4 | $185K | Sell |
4,090
-5,310
| -56% | -$241K | 0.04% | 79 |
|
|
2022
Q3 | $656K | Sell |
9,400
-1,960
| -17% | -$137K | 0.16% | 73 |
|
|
2022
Q2 | $763K | Buy |
11,360
+7,160
| +170% | +$481K | 0.18% | 74 |
|
|
2022
Q1 | $345K | Hold |
4,200
| – | – | 0.12% | 71 |
|
|
2021
Q4 | $616K | Buy |
4,200
+500
| +14% | +$73.3K | 0.13% | 83 |
|
|
2021
Q3 | $654K | Buy |
3,700
+3,330
| +900% | +$589K | 0.2% | 82 |
|
|
2021
Q2 | $60K | Sell |
370
-2,970
| -89% | -$482K | 0.02% | 106 |
|
|
2021
Q1 | $572K | Hold |
3,340
| – | – | 0.19% | 86 |
|
|
2020
Q4 | $734K | Buy |
3,340
+110
| +3% | +$24.2K | 0.24% | 86 |
|
|
2020
Q3 | $536K | Buy |
+3,230
| New | +$536K | 0.16% | 92 |
|
|
2020
Q2 | – | Sell |
-5,750
| Closed | -$442K | – | 118 |
|
|
2020
Q1 | $442K | Buy |
5,750
+3,600
| +167% | +$277K | 0.16% | 80 |
|
|
2019
Q4 | $277K | Buy |
+2,150
| New | +$277K | 0.11% | 77 |
|